Issue of Warrants
Summary by AI BETAClose X
4 December 2025
Sulnox Group Plc
(the "Company" or "Sulnox")
Issue of Warrants
(Aquis Stock Exchange: SNOX)
Sulnox, the greentech company delivering lower fuel costs and emissions with zero capex, is pleased to announce the issue of warrants (the "Warrants") previously announced on 3 December 2024, 11 December 2024 and 16 June 2025 (the "Announcements"). The Warrants are being issued to subscribers for new ordinary shares of 2 pence each ("Ordinary Shares"), as set out in the Announcements. The issue of the Warrants was conditional on new share allotment authorities being approved by the Company's shareholders; this was achieved at the annual general meeting of the Company held on 26 September 2025.
1,320,829 warrants have been issued with an exercise price of 58.8p, as set out in the announcement of 3 December 2024.
228.569 warrants have been issued with an exercise price of 66.1p, as set out in the announcement of 11 December 2024.
1,000,000 warrants have been issued with an exercise price of 60.0p, as set out in the announcement of 16 June 2025.
All the Warrants have an expiry date of 31 December 2028.
Among the investors receiving Warrants are two existing substantial shareholders of the Company, Constantine Logothetis and Nistadgruppen AS ("Nistad"). Mr Logothetis will receive 681,346 Warrants (via Arrowcove Ltd, a company he controls) and Nistad will receive 338,841 Warrants. As Mr Logothetis and Nistad each have an existing interest in more than 10% of the Company's Ordinary Shares, the issue of the Warrants constitutes related party transactions under the AQSE Growth Market Apex Rules. The Board has concluded, having exercised reasonable care, skill and diligence, that their Subscriptions are fair and reasonable as far as the shareholders of the Company are concerned.
ENDS
For further information please contact:
|
Sulnox Group plc Alex Judd, Head of Marketing & Communications |
|
|
Allenby Capital Limited (AQSE Corporate Adviser) Nick Harriss / John Depasquale (Corporate Finance) Amrit Nahal (Equity Sales) |
Tel: 020 3328 5656 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Sage Group
- 10 hours ago CVS Group
- 10 hours ago Helios Underwriting
- 11 hours ago Trustpilot Group
- 12 hours ago AJ Bell